Antibiotice Sa · BVB:ATB
Antibiotice Sa — Q1 2020 Earnings Presentation
21 slides from Antibiotice Sa's earnings presentation, June 2020
Slide 1: Prezentare companie
Write it here Prezentare companie
Slide 2: Tradition means continuity and recognition
Tradition means continuity and recognition Write it here ▪ Only a decade after the synthesis of Penicillin, Antibiotice, the first manufacturer of 1955 this active substance in Romania and South-Eastern Europe starts its activity. ▪ The manufacturing structure is developed, especially for active sub
Slide 3: Tradition means continuity and recognition
Tradition means continuity and recognition Pillar 1 Write it here Business internationalization and consolidation in the domestic market Pillar 2 Adapting strategically the product portfolio Our company’s development Pillar 3 through Operating cost management Strategic Plans Pillar 4 Adapting the hu
Slide 4: Antibiotice in the capital market
Antibiotice in the capital market Write it here Extract from the Shareholders’ Register on 27.03.2020 MINISTRY OF HEALTH 53.0173% S.I.F. OLTENIA (*), Others 18.9645% shareholders (41,795 shareholders), 15.7432% S.C. DEDEMAN S.R.L., 0.3407% BROADHURST INVESTMENTS LIMITED, 4.1977% FDI BT MAXIM ADM. BT
Slide 5: Listing history and trading on the stock exchange
Aprilie 1997 2005 2007 Write it here ATB shares have been included in the ATB shares have been included in Antibiotice have been listed in ROTX index on the Vienna Stock the Dow Jones Wilshire Global Total the PREMIUM categorybof the Exchange Bucharest Stock Exchage Market on the New York Stock Exch
Slide 6: Antibiotice today
Antibiotice today Write it here ➢ A portfolio comprising 150 pharmaceutical products in 12 therapeutic classes; ➢ 8 manufacturing flows for: penicillins powder for solution for injection; penicillin capsules; non-beta-lactam capsules; cephalosporin capsules; tablets; ointments, creams, gels; pessari
Slide 7: Domestic market
Domestic market Write it here Sales revenue recorded on 31.03.2020 by our company amounted to 73.63 million LEI, up 13% compared to the value recorded at the end of the first quarter of the previous year. This increase was determined by the 48.7% increase in the sales revenue in the Romanian market.
Slide 8: Antibiotice in Q I 2020 in the pharmaceutical market in Romania
Antibiotice in Q I 2020 in the pharmaceutical market in Romania Write it here Ranked 1st in the relevant market with a value market share of 13.8% at the end of Q I 2020; Leader in terms of quantity to the following dosage forms: ointments (23.3%), suppositories and pessaries (44.2%) and powders for
Slide 9: Research & Development
Research & Development Write it here The Research-Development activity has as its main objective the development of new medicines (topicals, tablets, capsules, sterile products and other new pharmaceutical dosage forms), in accordance with the strategic development directions of the company until 20
Slide 10: Antibiotice supports the Romanian medical system
Antibiotice supports the Romanian medical system Write it here Our company resumed the production of Paracetamol and Novocalmin® because they have been included in most national guidelines in EU as the first option when initiating the treatment for fever or pain caused by the COVID 19 infection. Suc
Slide 11: Production of the Antibiotice company
Production of the Antibiotice company Write it here • 135 million pharmaceutical units under the form of tablets, capsules, parenteral products, topicals (ointments, creams, gels), suppositories and pessaries; • 139 thousand BOU active substance (Nystatin) The total value of production in the first
Slide 12: Business internationalization
Business internationalization Write it here Our business develops internationally in 2020 focusing on the following directions: Nystatin API – to consolidate and Nystatin sales increased by 13% compared to the planned level maintain the leading position in and by 27% compared to the same period of 2
Slide 13: Actions completed in the first quarter of 2020
Actions completed in the first quarter of 2020 Write it here ➢ Clarithromycin tablets 500 mg, a new anti-infective product was launched in the Vietnamese market; ➢ Our specialists conducted a market study and completed the negotiations by establishing a long-term partnership with a local distributor
Slide 14: Comprehensive income statement
Comprehensive income statement Write it here Comprehensive income statement (LEI) 31.03.2019 31.03.2020 2020/2019 1 2 3 4=3/2 Sales revenue 65.066.014 73.631.604 1,13 Other operating revenues 8.952.087 6.716.382 0,75 Revenue related to the costs of product 16.661.315 14.301.700 0,86 stocks Income fr
Slide 15: Statement of financial position
Statement of financial position 31.03.2020 / WritePatrimonial it here elements (lei) 01.01.2020 31.03.2020 01.01.2020 1 2 3 4 = 3/2 ASSETS FIXED ASSETS Tangible fixed assets 363.616.611 378.105.379 1,04 Intangible assets 16.385.709 16.426.775 1,00 TOTAL FIXED ASSETS 380.002.320 394.532.154 1,04 CURR
Slide 16: Statement of financial position
Statement of financial position Write it here TOTAL LIABILITIES 297.172.576 301.279.946 1,01 Share capital and reserves Share capital 264.835.156 264.835.156 1,00 Revaluation reserves 50.804.319 50.151.664 0,99 Legal reserves 13.426.761 13.426.761 1,00 Other reserves 200.655.367 200.655.367 1,00 Ret
Slide 17: Investment breakdown
Investment breakdown Write it here Planned 2020: 23.74 mil. LEI Achieved Q1: 8.25 mil. LEI Planned 2020: 23.74 mil. LEI Achieved Q1: 8.25 mil. LEI Planned 2020: 3.33 mil. LEI Achieved Q1: 1.31 mil. LEI Planned 2020: 3.20 mil. LEI Achieved Q1: 0.15 mil. LEI Investments in Planned 2020: 19.64 mil. LEI
Slide 18: Measures Against the COVID-19 outbreak
Measures Write it here Against the COVID-19 outbreak Scenario 1 To reduce the indirectly productive activities by working from home. SCENARIO 1 Scenario 3 ATB – forced in two cases CRISIS TEAM (a confirmed case or if obliged by the authorities) to stop SCENARIO 3 SCENARIO 2 Scenario 2 the productive
Slide 19: The first measures taken to protect the health of our employees
The first measures taken to protect the health of our employees: • Write it here installation of disinfectant dispensers and disinfectant rubber mats at each workplace and at all the main entrances; • providing employees with the necessary sanitary and protective materials on a daily basis: masks, g
Slide 20: Conclusions
Write it here Conclusions Antibiotice in the first quarter of 2020: ❖ Sales revenue increased by 13% compared to the value recorded in the same period of the previous year; ❖ Operating profit up 6%, compared to the value recorded in the same period of the previous year; ❖ Our company supports the pu
Slide 21: Thank you!
Thank you! 2020